| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/19/2003 | CN1397564A Mutant of human tissue type plasminogen activator |
| 02/19/2003 | CN1397521A Liquid-state composite bacterial microbe fertilizer and its preparing process |
| 02/19/2003 | CN1397346A Genetically engineered rabies virus vaccine with recombination-defective adenovirus carrier |
| 02/19/2003 | CN1101937C Methodology for selecting superagonists, antagonists and superantagonist of hormones whose receptor complex includes GP 130 |
| 02/19/2003 | CN1101854C G protein coupled receptor protein, prodn. and use thereof |
| 02/19/2003 | CN1101852C Recombined Chinese bollworm virus |
| 02/19/2003 | CA2463490A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2003 | CA2420065A1 Methods for indentifying specifically cleavable peptides and use of such peptide sequences |
| 02/18/2003 | US6521818 Development of novel highly chemoprotectant crucifer germplasm |
| 02/18/2003 | US6521816 Nucleic acid molecules from rice and their use for the production of modified starch |
| 02/18/2003 | US6521815 Screening for putative agents; cells with higher epidermal expression of protein kinase C; inducing tumors, metastasis, and/or cancer |
| 02/18/2003 | US6521814 Use of ligands for treatment of diseases responsive to retinoids |
| 02/18/2003 | US6521751 Recombinant nucleic acid sequences and methods for determining both genotoxicity and mutagenicity of a sample and the kinetics of the genotoxicity |
| 02/18/2003 | US6521750 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 02/18/2003 | US6521749 GL50 nucleic acids and uses therefor |
| 02/18/2003 | US6521748 Polynucleotide encoding a mutant Rhodotorula glutinis tyrosine ammonia lyase polypeptide |
| 02/18/2003 | US6521747 Haplotypes of the AGTR1 gene |
| 02/18/2003 | US6521746 Leukotoxin polypeptide fused to gonadotropin releasing hormone/factor multimer; increased immunogenicity |
| 02/18/2003 | US6521745 Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
| 02/18/2003 | US6521742 Human endokine alpha |
| 02/18/2003 | US6521741 Catalytic antibodies and a method of producing same |
| 02/18/2003 | US6521740 Expression vectors; genetic engineering |
| 02/18/2003 | US6521739 Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey |
| 02/18/2003 | US6521738 Method for making insulin precursors and insulin precursor analogs |
| 02/18/2003 | US6521602 Anti-neoplastic compositions and uses thereof |
| 02/18/2003 | US6521601 Selecting a DNA fragment having sequence recognized by a viral specific transcription factor and complementary segment |
| 02/18/2003 | US6521596 Lanthionine antibiotic compositions and method |
| 02/18/2003 | US6521590 Amino acid sequence containing cysteine/glycine domain of chitin binding plant proteins; better activity against pathogenic fungi; transgenic plants expressing the protein show increased disease resistance |
| 02/18/2003 | US6521458 Killing plant cells that receive non-T-DNA sequences derived from T-DNA vector; transformation, gene expression |
| 02/18/2003 | US6521457 Lentivirus-based gene transfer vectors |
| 02/18/2003 | US6521456 Gene therapy for cancer; treating viral infections, nervous system disorders, graft rejection, and monogenic or polygenic disorders |
| 02/18/2003 | US6521455 Viral polypeptide for use as tool in genetic engineering and gene therapy |
| 02/18/2003 | US6521453 Oligonucloetide mediated nucleic acid recombination |
| 02/18/2003 | US6521450 Cells expressing a modified regulator of complement activation |
| 02/18/2003 | US6521449 Enhancer from immunoglobulin; polyadenylation site; gene therapy |
| 02/18/2003 | US6521448 Porcine MHC class I genes and uses thereof |
| 02/18/2003 | US6521442 Polynucleotide compositions encoding broad spectrum δ-endotoxins |
| 02/18/2003 | US6521441 Staphylococcus aureus genes and polypeptides |
| 02/18/2003 | US6521440 Proteases from gram-positive organisms |
| 02/18/2003 | US6521438 Chemoreceptors in plant parasitic nematodes |
| 02/18/2003 | US6521437 Human sphingosine lyase polypeptides |
| 02/18/2003 | US6521436 Gene expression; drug screening for antiarthritic agents; bone disorders |
| 02/18/2003 | US6521435 Glucanase, endochitinase, and exochitinase; enhancing resistance in plants |
| 02/18/2003 | US6521434 Nucleotide sequences coding enzymatic polypeptide; for use as a bactericide |
| 02/18/2003 | US6521433 Polynucleotide encodes isoflavone reductase |
| 02/18/2003 | US6521427 Annealing oligonucleotides in assembling artificial organisms |
| 02/18/2003 | US6521426 Incubation with heper adenovirus vector; gene expression of proteins required for genomic replication |
| 02/18/2003 | US6521425 Screening and use of reagents which block or activate intein splicing utilizing natural or homologous exteins |
| 02/18/2003 | US6521423 Intracellular production of Hepatitis C E2 polypeptides |
| 02/18/2003 | US6521422 Fhm, a novel member of the TNF ligand supergene family |
| 02/18/2003 | US6521420 Gene expression; diagnosing high blood pressure |
| 02/18/2003 | US6521419 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 02/18/2003 | US6521417 Incubating permeabilized cells expressing mutant kinase with radiolabeled analog; cytolysis, separation by sodium dodecyl sulfate polyacrylamide gel electrophoresis |
| 02/18/2003 | US6521413 Bioassay; monitoring cells for changes in ion channel activity |
| 02/18/2003 | US6521412 Drug screening for anticarcinogenic agents and agents to treat atherosclerosis and neurodegenerative disorders |
| 02/18/2003 | US6521411 Generating nucleotide sequences libraries; obtain nucleotide sequences, apply to column, elute nuclleotide sequences, recover sequences, generate complimentary nuclelotide sequences library |
| 02/18/2003 | US6521410 Mutant of tissue factor pathway inhibitor, DNA sequence and use for detecting thrombotic disorders |
| 02/18/2003 | US6521408 Complementation; ligating genome fragments to binary shuttle vectors; adding to Agrobacterium cell; transformation, evaluation |
| 02/18/2003 | US6521407 Methods for determining chemosensitivity of cancer cells based upon expression of negative and positive signal transduction factors |
| 02/18/2003 | US6521406 From Saccharopolyspora; genetic engineering |
| 02/18/2003 | US6521404 Gene expression of library bacteriophage particles with very light domain antibodies and synthetic very heavy antibodies displayed on surface |
| 02/18/2003 | US6521403 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
| 02/18/2003 | US6521252 Comprises one or several disulphide bonds; cationic lipid type |
| 02/18/2003 | US6521236 Vector vaccine of recombinant feline herpesvirus |
| 02/18/2003 | US6521235 Alphavirus RNA replicon systems |
| 02/18/2003 | US6521234 NL3 TIE ligand homologue |
| 02/18/2003 | US6521232 Proteins having immunomodulatory activity and remedies for immunological diseases |
| 02/18/2003 | US6521231 Pseudorabies virus protein |
| 02/18/2003 | US6521230 CD25 binding molecules |
| 02/18/2003 | US6521228 Monoclonal antibodies having preferential binding to human tumor necrosis factor related apoptosis inducing ligand(TRAIL) polypeptides; cytokines used as anticarcinogenic agents |
| 02/18/2003 | US6521225 AAV vectors |
| 02/18/2003 | US6521181 Microfabricated electrochemiluminescence cell for chemical reaction detection |
| 02/18/2003 | CA2283751C Frozen food product containing anti-freeze peptides |
| 02/18/2003 | CA2100591C Avirulent anti-rabies vaccine |
| 02/18/2003 | CA2080213C Diagnostic reagent for hepatitis c |
| 02/18/2003 | CA2075366C Immunologically active peptides or polypeptides from the parvovirus b19 |
| 02/18/2003 | CA2071211C Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
| 02/18/2003 | CA2067031C Dna coding for human cell surface antigen |
| 02/18/2003 | CA2064331C Vascular endothelial cell growth factor c subunit |
| 02/18/2003 | CA2061382C Method for producing cysteine-free peptide |
| 02/17/2003 | CA2356390A1 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 02/15/2003 | CA2392309A1 Neuropeptide receptor and uses thereof |
| 02/15/2003 | CA2392305A1 Adrenic acid receptor and uses thereof |
| 02/13/2003 | WO2003012451A2 Methods for detecting of intermoleculair interactions using protein arrays |
| 02/13/2003 | WO2003012448A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012411A1 Method of evaluating uniformity of spots in arrays |
| 02/13/2003 | WO2003012394A2 Androgen receptor knock-out transgenic animals |
| 02/13/2003 | WO2003012393A2 Method of detecting protease activity in a cell |
| 02/13/2003 | WO2003012148A2 Molecular vector for the genophenotypic characterisation of v3 sequences of hiv-1 gp120 |
| 02/13/2003 | WO2003012146A1 Modular assembly of nucleic acid-protein fusion multimers |
| 02/13/2003 | WO2003012145A1 Antisense modulation of dual specific phosphatase 8 expression |
| 02/13/2003 | WO2003012144A1 Antisense modulation of acyl coenzyme a cholesterol acyltransferase-1 expression |
| 02/13/2003 | WO2003012143A1 Genes and snps associated with eating disorders |
| 02/13/2003 | WO2003012140A1 Method of analyzing nucleic acid specifying gene showing change in expression dose in schizophrenia |
| 02/13/2003 | WO2003012139A2 Methods for assessing the risk of obesity based on allelic variations in the 5'-flanking region of the insulin gene |
| 02/13/2003 | WO2003012137A2 Methods for detecting parkinson's disease |
| 02/13/2003 | WO2003012136A2 Method to detect splice variants of the calcineurin gene |
| 02/13/2003 | WO2003012130A1 Methods for generating antibiotic resistant microbes and novel antibiotics |
| 02/13/2003 | WO2003012127A2 Assay for identifying inhibitors of hiv rt dimerization |